162
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Expression Profile and Gene Regulation Network of NUSAP1 in Pan Cancers Based on Integrated Bioinformatics Analysis

, , , , , , & show all
Pages 4235-4248 | Received 12 Apr 2023, Accepted 31 Aug 2023, Published online: 18 Sep 2023

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
  • Myant KB, Cammareri P, Hodder MC, et al. HUWE 1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation. Embo Mol Med. 2017;9(9):181–197. doi:10.15252/emmm.201606684
  • Colecchia D, Rossi M, Sasdelli F, Sanzone S, Strambi A, Chiariello M. MAPK15 mediates BCR-ABL1-induced autophagy and regulates oncogene-dependent cell proliferation and tumor formation. Autophagy. 2015;11:1790–1802. doi:10.1080/15548627.2015.1084454
  • Mullard A. New checkpoint inhibitors ride the immunotherapy tsunami. Nat Rev Drug Discov. 2013;12:489–492. doi:10.1038/nrd4066
  • Li Q, Yuan D, Ma C, et al. A new hope: the immunotherapy in small cell lung cancer. Neoplasma. 2016;63:342–350. doi:10.4149/302_151001N511
  • Han Y, Wu Y, Yang C, et al. Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy. J Transl Med. 2017;15:15. doi:10.1186/s12967-016-1116-1
  • Raemaekers T, Ribbeck K, Beaudouin J, et al. NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J Cell Biol. 2003;162:1017–1029. doi:10.1083/jcb.200302129
  • Gordon CA, Gong X, Ganesh D, Brooks JD. NUSAP1 promotes invasion and metastasis of prostate cancer. Oncotarget. 2017;8:29935. doi:10.18632/oncotarget.15604
  • Qian Z, Li Y, Ma J, et al. Prognostic value of NUSAP1 in progression and expansion of glioblastoma multiforme. J Neuro Oncol. 2018;140:199–208. doi:10.1007/s11060-018-2942-1
  • Liu Z, Guan C, Lu C, et al. High NUSAP1 expression predicts poor prognosis in colon cancer. Pathology Res Pract. 2018;214:968–973. doi:10.1016/j.prp.2018.05.017
  • Li H, Zhang W, Yan M, et al. Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/β-catenin signaling. J Exp Clin Canc Res. 2019;38:38. doi:10.1186/s13046-019-1046-x
  • Wu X, Xu B, Yang C, et al. Nucleolar and spindle associated protein 1 promotes the aggressiveness of astrocytoma by activating the Hedgehog signaling pathway. J Exp Clin Canc Res. 2017;36(36). doi:10.1186/s13046-017-0597-y
  • Persis P, Wadia MC, Armstrong RJ, Mindrinos M, Butte AJ, Miklos DB. Antibodies specifically targetAMLantigen NuSAP1 after allogeneic bone marrow transplantation. Blood. 2010;115:2077–2087. doi:10.1182/blood-2009-03-211375
  • Ge Y, Li Q, Lin L, et al. Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer. Cell Biochem Funct. 2019;38:28–37. doi:10.1002/cbf.3444
  • Zhang Y, Huang K, Cai H, Chen S, Sun D, Jiang P. The role of nucleolar spindle‐associated protein 1 in human ovarian cancer. J Cell Biochem. 2020;121(11):4397–4405.
  • Sun L, Shi C, Liu S, et al. Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis. Gene. 2020;747:144657. doi:10.1016/j.gene.2020.144657
  • Xu Z, Wang Y, Xiong J, Cui F, Wang L, Peng H. NUSAP1 knockdown inhibits cell growth and metastasis of non‐small‐cell lung cancer through regulating BTG2/PI3K/Akt signaling. J Cell Physiol. 2019;235:3886–3893. doi:10.1002/jcp.29282
  • Zhang X, Pan Y, Fu H, Zhang J. Nucleolar and spindle associated protein 1 (NUSAP1) inhibits cell proliferation and enhances susceptibility to epirubicin in invasive breast cancer cells by regulating cyclin D kinase (CDK1) and DLGAP5 expression. Med Sci Monitor. 2018;24(24):8553–8564. doi:10.12659/MSM.910364
  • Gao S, Yin H, Tong H, et al. Nucleolar and spindle associated protein 1 (NUSAP1) promotes bladder cancer progression through the TGF-β signaling pathway. Oncotargets Ther. 2020;13:813–825. doi:10.2147/OTT.S237127
  • Chen M, Cen K, Song Y, et al. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma. Cancer Lett. 2023;567:216285. doi:10.1016/j.canlet.2023.216285
  • Serin EAR, Nijveen H, Hilhorst HWM, Ligterink W. Learning from co-expression networks: possibilities and challenges. Front Plant Sci. 2016;7. doi:10.3389/fpls.2016.00444
  • Wang L, Li Y, Chen G. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma. PLoS One. 2018;13:e190447.
  • Gov E, Arga KY. Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer. Sci Rep. 2017;2017:7.
  • Wang Y, Chen L, Ju L, et al. Novel biomarkers associated with progression and prognosis of bladder cancer identified by co-expression analysis. Front Oncol. 2019;2019:9.
  • Zhao Q, Song W, He DY, Li Y. Identification of key gene modules and pathways of human breast cancer by co-expression analysis. Breast Cancer Tokyo. 2018;25:213–223. doi:10.1007/s12282-017-0817-5
  • Wadia PP, Coram M, Armstrong RJ. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 2015;43(43):W566–70. doi:10.1093/nar/gkv468
  • Jiao X, Sherman BT, Huang DW, et al. DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics. 2012;28(28):1805–1806. doi:10.1093/bioinformatics/bts251
  • Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Immunotherapy of cancer in 2012. CA Cancer J Clin. 2012;62:309–335. doi:10.3322/caac.20132
  • Mahoney KM, Rennert PD, Freeman GJ. Combination cancer immunotherapy and new immunomodulatory targets. Nat Rev Drug Discov. 2015;14:561–584. doi:10.1038/nrd4591
  • Dong Z, Zhong W, Zhang X, et al.Potential Predictive Value of TP53 and KRAS mutation status for response to PD-1 blockade immunotherapy in lung adenocarcinoma. Clin Cancer Res. 2017;(23):3012–3024. doi:10.1158/1078-0432.CCR-16-2554
  • Xu F, Yin C, Wang C, et al. Immunophenotypes and immune markers associated with acute promyelocytic leukemia prognosis. Dis Markers. 2014;2014:1–6.
  • Pan H, Wang X, Huang W, et al. Interferon-induced protein 44 correlated with immune infiltration serves as a potential prognostic indicator in head and neck squamous cell carcinoma. Front Oncol. 2020;10:10. doi:10.3389/fonc.2020.00010
  • Lambert SA, Jolma A, Campitelli LF, et al. The human transcription factors. Cell. 2018;172:650–665. doi:10.1016/j.cell.2018.01.029
  • Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–838. doi:10.1038/nature03702
  • Fan Y, Zhang L, Sun Y, et al. Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human. Cancer Gene Ther. 2020;27:216–225. doi:10.1038/s41417-019-0087-9
  • Yang M, Huang W, Sun Y, et al. Prognosis and modulation mechanisms of COMMD6 in human tumours based on expression profiling and comprehensive bioinformatics analysis. Brit J Cancer. 2019;121(121):699–709. doi:10.1038/s41416-019-0571-x
  • Wang YU, Yan S, Liu X, et al. miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma. Oncol Rep. 2014;31:1905–1910. doi:10.3892/or.2014.3046
  • An J, Ma M, Zhang C, Shao S, Zhou N, Dai D. miR-1236-3p inhibits invasion and metastasis in gastric cancer by targeting MTA2. Cancer Cell Int. 2018;18:18. doi:10.1186/s12935-018-0516-0
  • Bian T, Jiang D, Liu J, et al. miR-1236-3p suppresses the migration and invasion by targeting KLF8 in lung adenocarcinoma A549 cells. Biochem Bioph Res Co. 2017;492:461–467. doi:10.1016/j.bbrc.2017.08.074
  • Li C, Cai S, Wang X, Jiang Z. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer. PLoS One. 2014;9:e112005. doi:10.1371/journal.pone.0112005
  • Shen X, Yuan J, Zhang M, et al. The increased expression of TCF3 is correlated with poor prognosis in Chinese patients with nasopharyngeal carcinoma. Clin Otolaryngol. 2017;42:824–830. doi:10.1111/coa.12834
  • Liu Z, Wu M, Shi H, Huang C, Luo S, Song X. DDN‐AS1‐miR‐15a/16‐TCF3 feedback loop regulates tumor progression in cervical cancer. J Cell Biochem. 2018;120:10228–10238. doi:10.1002/jcb.28307
  • Pu X, Zheng D, Lv T, Zhou Y, Yang J, Jiang L. Overexpression of transcription factor 3 drives hepatocarcinoma development by enhancing cell proliferation via activating Wnt signaling pathway. Hepatob Pancreat Dis. 2022;21:378–386. doi:10.1016/j.hbpd.2022.01.003